| Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and … M Perera, N Papa, D Christidis, D Wetherell, MS Hofman, DG Murphy, ... European urology 70 (6), 926-937, 2016 | 1156 | 2016 |
| Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution … M Perera, N Papa, M Roberts, M Williams, C Udovicich, I Vela, ... European urology 77 (4), 403-417, 2020 | 899 | 2020 |
| Laser ablation of the prostate in patients with benign prostatic hypertrophy AJ Costello, WG Bowsher, DM Bolton, KG Braslis, J Burt British journal of urology 69 (6), 603-608, 1992 | 465 | 1992 |
| Re: Five Year Results of the Prospective Randomized Controlled Prostatic Urethral LIFT Study SA Kaplan Journal of Urology 200 (5), 920-921, 2018 | 358 | 2018 |
| Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma S RAMDAVE, GW THOMAS, SU Berlangieri, DM Bolton, IAN Davis, ... The Journal of urology 166 (3), 825-830, 2001 | 262 | 2001 |
| The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT Study CG Roehrborn, SN Gange, ND Shore, JL Giddens, DM Bolton, BE Cowan, ... The Journal of urology 190 (6), 2161-2167, 2013 | 261 | 2013 |
| Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ... Nature communications 8 (1), 13671, 2017 | 255 | 2017 |
| Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy EJ Hamilton, E Gianatti, BJ Strauss, J Wentworth, D Lim‐Joon, D Bolton, ... Clinical endocrinology 74 (3), 377-383, 2011 | 234 | 2011 |
| 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review J Corfield, M Perera, D Bolton, N Lawrentschuk World journal of urology 36, 519-527, 2018 | 203 | 2018 |
| Nd: YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy AJ Costello, DE Johnson, DM Bolton Lasers in surgery and medicine 12 (2), 121-124, 1992 | 199 | 1992 |
| The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome A Fuller, H Razvi, JD Denstedt, L Nott, M Pearle, F Cauda, D Bolton, ... The Journal of urology 188 (1), 138-144, 2012 | 174 | 2012 |
| Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia PT Chin, DM Bolton, G Jack, P Rashid, J Thavaseelan, RJ Yu, ... Urology 79 (1), 5-11, 2012 | 171 | 2012 |
| Carbon footprint in flexible ureteroscopy: a comparative study on the environmental impact of reusable and single-use ureteroscopes NF Davis, S McGrath, M Quinlan, G Jack, N Lawrentschuk, DM Bolton Journal of endourology 32 (3), 214-217, 2018 | 161 | 2018 |
| Indirect comparisons of efficacy between combination approaches in metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis NJ Sathianathen, S Koschel, IA Thangasamy, J Teh, O Alghazo, ... European urology 77 (3), 365-372, 2020 | 160 | 2020 |
| Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor … GP Risbridger, RA Taylor, D Clouston, A Sliwinski, H Thorne, S Hunter, ... European Urology 67 (3), 496-503, 2015 | 159 | 2015 |
| Three year results of the prostatic urethral LIFT study C Roehrborn, DB Rukstalis, J Barkin, SN Gange, ND Shore, JL Giddens, ... Canadian Journal of Urology 22 (3), 7772-7782, 2015 | 151 | 2015 |
| Minimally invasive prostatic urethral lift: surgical technique and multinational experience TA McNicholas, HH Woo, PT Chin, D Bolton, MF Arjona, KD Sievert, ... European urology 64 (2), 292-299, 2013 | 151 | 2013 |
| Assessing regional hypoxia in human renal tumours using 18F‐fluoromisonidazole positron emission tomography N Lawrentschuk, AMT Poon, SS Foo, LGJ Putra, C Murone, ID Davis, ... BJU international 96 (4), 540-546, 2005 | 143 | 2005 |
| Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review N Lawrentschuk, J Gani, R Riordan, S Esler, DM Bolton BJU international 96 (3), 291-295, 2005 | 142 | 2005 |
| Cancer in lockdown: impact of the COVID‐19 pandemic on patients with cancer H Moraliyage, D De Silva, W Ranasinghe, A Adikari, D Alahakoon, ... The oncologist 26 (2), e342-e344, 2021 | 141 | 2021 |
Professor Nathan LawrentschukUniversity of Melbourne, Royal Melbourne Hospital, AustraliaEmail được xác minh tại unimelb.edu.au